Papillitis is a form of optic neuritis localised to the optic nerve head. It is characterised by inflammatory swelling of the optic disc and produces visible disc oedema detectable on fundoscopy.1 The term is often used interchangeably with anterior optic neuritis.
Clinically, distinguishing acute versus chronic papillitis is of major importance. Acute forms typically arise abruptly, often in young adults, with symptoms such as painful visual loss and disc hyperemia, whereas chronic papillitis manifests with progressive, painless decline in vision and longstanding optic nerve head changes.2,3,4 The ability to differentiate between these two entities is not only diagnostic but also prognostic, as underlying causes and outcomes differ substantially.
Pathophysiologically, acute papillitis often results from transient inflammatory demyelination, immune-mediated reactions, or infection, while chronic papillitis is more frequently due to persistent compression, granulomatous inflammation, ischemia, or metabolic/toxic insults leading to sustained axonal damage.5,6,7 If unrecognised, chronic cases can lead to optic atrophy and irreversible blindness.
Given the overlap of symptoms with other neuro-ophthalmic conditions, such as papilledema or ischemic optic neuropathy, it is necessary to perform clinical and paraclinical evaluation. This article reviews the key differences in aetiology, clinical features, diagnostic work-up, prognosis, and management of acute versus chronic papillitis, highlighting practical points for clinicians.
Etiology
Acute Papillitis
- The most common cause of acute papillitis is demyelinating disease, especially multiple sclerosis (MS). Optic neuritis is the presenting feature in 15–20% of MS patients, and approximately half of those with optic neuritis eventually develop MS1,2
- Infections: Viral illnesses such as herpes zoster, measles, mumps, and influenza may trigger papillitis either by direct invasion or post-infectious immune mechanisms. Bacterial causes can be from conditions such as syphilis, Lyme disease, and tuberculosis3
- Autoimmune/inflammatory causes: Neuromyelitis optica spectrum disorder (NMOSD), sarcoidosis, and systemic lupus erythematosus are increasingly recognised triggers. NMOSD tends to cause severe, bilateral, and recurrent attacks of optic neuritis, which may involve papillitis6
- Parainfectious/post-vaccination: Papillitis may follow vaccination or systemic infections, reflecting aberrant immune activation
Chronic Papillitis
Chronic optic disc inflammation is usually secondary to persistent pathology:
- Compressive lesions: Orbital or intracranial tumors (meningiomas, gliomas), aneurysms, or enlarged extraocular muscles in thyroid eye disease can chronically compress the optic nerve, producing slow swelling4
- Chronic inflammatory diseases: Sarcoidosis, granulomatosis with polyangiitis, or tuberculous meningitis may chronically involve the optic nerve head6
- Ischemic optic neuropathy: Chronic hypoperfusion, often in older patients with hypertension, diabetes, or arteriosclerosis, can mimic chronic papillitis4
- Toxic/metabolic causes: Long-term use of drugs such as ethambutol, isoniazid, or exposure to methanol can damage the optic nerve. Nutritional deficiencies (e.g., B12) may produce similar findings7
Clinical presentation
Acute Papillitis
- Onset: Develops over hours or days
- Symptoms: Pain with eye movements is a feature, particularly in demyelinating cases.1,2 Patients often notice blurred or dim vision, central scotomas, or loss of colour discrimination
- Visual acuity: Can range from mild reduction to severe impairment
- Pupillary findings: A relative afferent pupillary defect (RAPD) is typically present in unilateral cases
- Fundus: Optic disc swelling with hyperemia, blurred margins, and variable haemorrhages or exudates. Peripapillary retinal folds may be seen3
- Associated features: Uhthoff’s phenomenon (worsening of vision with heat or exercise) and photopsias (flashes of light)
Chronic Papillitis
- Onset: Slow and often takes weeks to months.
- Symptoms: Gradual, painless visual decline. Patients may not notice until significant field loss occurs
- Visual fields: Peripheral constriction or altitudinal loss predominates4,6
- Fundus: Optic disc swelling is present but less hyperemic. Gliotic changes and pallor may appear as the process advances. Over time, optic atrophy with a pale disc develops
- Systemic associations: Chronic cases often occur with systemic disease, such as sarcoidosis, compressive tumours, and vascular disease7
Diagnostic Work-Up
- Ophthalmoscopy/fundoscopy: Essential for differentiating papillitis from papilledema. Papillitis is usually unilateral, painful, and associated with visual loss, while papilledema is bilateral, painless, and vision is preserved until late5
- Optical coherence tomography (OCT): Provides an objective measurement of retinal nerve fiber layer (RNFL) swelling in acute cases. Chronic cases show thinning of the fiber layer6
- Visual field testing: Automated perimetry helps document central scotomas in acute papillitis and peripheral defects in chronic cases1,3
- MRI (brain and orbits with contrast): In acute demyelinating papillitis, T2 hyperintensity and gadolinium enhancement of the optic nerve are common. Chronic papillitis due to compression or infiltrative disease is best visualised by MRI or CT2,5
- Laboratory investigations
- Serologies for syphilis, Lyme, HIV, or tuberculosis.
- Autoimmune screening (ANA, ANCA, aquaporin-4 antibodies in NMOSD).
- Vitamin B12 and toxin exposure history7
Prognosis
Acute papillitis
Most demyelinating cases recover partially or fully within 6–12 weeks, although subtle deficits in contrast sensitivity and color vision may persist.1,2 Recurrence increases the risk of multiple sclerosis. Long-term prognosis is generally good, but permanent deficits may occur in NMOSD or severe infections.6
Chronic papillitis
Prognosis is guarded. Continuous inflammation or compression often results in irreversible optic atrophy. Visual outcome depends largely on early identification and treatment of the underlying cause.4,6
Management
Acute Papillitis
- Demyelinating disease: Intravenous methylprednisolone accelerates recovery but does not alter long-term visual outcome or MS risk2
- Infections: Treat with pathogen-specific antimicrobials (e.g., penicillin for syphilis, doxycycline for Lyme, antitubercular therapy for TB)
- NMOSD or autoimmune causes: Require immunosuppression (rituximab, azathioprine, mycophenolate mofetil) to prevent recurrences6
Chronic Papillitis
- Compressive lesions: Neurosurgical or ophthalmic decompression is often needed. Radiotherapy may be used in tumours like optic nerve sheath meningioma
- Chronic inflammatory disease: Long-term corticosteroids or immunosuppressants (methotrexate, cyclophosphamide)
- Ischemic optic neuropathy: Control systemic risk factors; no proven therapy reverses established damage4
- Toxic/nutritional cases: Remove exposure (e.g., ethambutol cessation) and correct deficiencies (e.g., vitamin B12 replacement)7
Summary
In its acute form, individuals diagnosed with papillitis often notice a sudden, painful drop in vision, usually accompanied by a swollen and hyperemic disc. These cases are most often linked to demyelinating disease or infection, and with the right treatment, many individuals regain a good level of visual function.
The chronic form tends to be far more subtle. Vision declines slowly, and pain is usually absent, which means it may present late, after significant damage has already occurred. Causes are often structural or systemic, like compressive tumours, vascular disease, or chronic inflammatory disorders. Unfortunately, chronic papillitis carries a higher risk of ending in optic atrophy and permanent visual loss if left untreated.
Being able to recognise the difference early is important. Careful examination, supported by imaging and targeted laboratory tests, allows clinicians to distinguish acute from chronic disease, uncover the underlying cause, and intervene before permanent damage is done. By keeping these patterns in mind, we can improve outcomes, preserve vision, and in some cases, identify important systemic diseases that might otherwise go unnoticed.
References
- Toosy AT, Mason DF, Miller DH. Optic neuritis. Lancet Neurol. 2014;13(1):83–99.
- Hickman SJ, Dalton CM, Miller DH, Plant GT. Management of acute optic neuritis. Lancet. 2002;360(9349):1953–62.
- Balcer LJ. Clinical practice. Optic neuritis. N Engl J Med. 2006;354(12):1273–80.
- Levin LA, Arnold AC. Optic neuritis and ischemic optic neuropathy: overlapping clinical profiles, pathophysiologies, and treatment strategies. Semin Ophthalmol. 2011;26(5-6):286–97.
- Kline LB, Bajandas FJ. Neuro-ophthalmology Review Manual. 7th ed. Thorofare, NJ: SLACK Inc; 2013.
- Petzold A, Fraser CL, Abegg M, et al. Diagnosis and classification of optic neuritis. Lancet Neurol. 2022;21(12):1120–34.
- Behbehani R. Clinical approach to optic neuropathies. Clin Ophthalmol. 2007;1(3):233–46.

